Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
1.050
+0.010 (0.96%)
At close: Jul 19, 2024, 4:00 PM
0.950
-0.100 (-9.52%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Cytosorbents Revenue
Cytosorbents had revenue of $36.69M in the twelve months ending March 31, 2024, with 3.50% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $9.79M with 3.56% year-over-year growth. In the year 2023, Cytosorbents had annual revenue of $36.35M with 4.79% growth.
Revenue (ttm)
$36.69M
Revenue Growth
+3.50%
P/S Ratio
1.55
Revenue / Employee
$197,238
Employees
186
Market Cap
57.02M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 36.35M | 1.66M | 4.79% |
Dec 31, 2022 | 34.69M | -8.48M | -19.64% |
Dec 31, 2021 | 43.17M | 2.16M | 5.27% |
Dec 31, 2020 | 41.00M | 16.06M | 64.35% |
Dec 31, 2019 | 24.95M | 2.45M | 10.87% |
Dec 31, 2018 | 22.50M | 7.35M | 48.53% |
Dec 31, 2017 | 15.15M | 5.62M | 59.02% |
Dec 31, 2016 | 9.53M | 4.74M | 98.84% |
Dec 31, 2015 | 4.79M | 668.79K | 16.22% |
Dec 31, 2014 | 4.12M | 1.70M | 70.18% |
Dec 31, 2013 | 2.42M | 1.08M | 80.40% |
Dec 31, 2012 | 1.34M | 1.31M | 3,622.31% |
Dec 31, 2011 | 36.08K | - | - |
Dec 31, 2010 | 0 | - | - |
Dec 31, 2009 | 0 | - | - |
Dec 31, 2008 | 0 | - | - |
Dec 31, 2007 | 0 | - | - |
Dec 31, 2006 | 0 | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Neuronetics | 73.23M |
LENSAR | 44.50M |
Cryo-Cell International | 31.64M |
CollPlant Biotechnologies | 10.62M |
Adlai Nortye | 5.00M |
CTSO News
- 5 days ago - CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress - GlobeNewsWire
- 20 days ago - CytoSorbents Secures $20 Million Credit Facility - GlobeNewsWire
- 6 weeks ago - CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting - GlobeNewsWire
- 2 months ago - CytoSorbents Reports First Quarter 2024 Results - GlobeNewsWire
- 3 months ago - CytoSorbents to Report First Quarter 2024 Operating and Financial Results - GlobeNewsWire
- 3 months ago - STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting - GlobeNewsWire
- 4 months ago - CytoSorbents Reports Fourth Quarter and Full Year 2023 Results - GlobeNewsWire
- 4 months ago - CytoSorbents to Report Fiscal 2023 Operating and Financial Results - GlobeNewsWire